Neither Benzoyl Peroxide Nor Tretinoin Are Recommended Treatments for Molluscum Contagiosum
Neither benzoyl peroxide nor tretinoin should be used as primary treatment for molluscum contagiosum, as these agents are indicated for acne vulgaris, not viral skin infections. The available evidence shows these medications target different pathophysiologic mechanisms (acne bacteria and comedones) rather than the poxvirus causing molluscum.
Why These Agents Are Not Appropriate
Benzoyl Peroxide
- Indicated exclusively for acne treatment through antibacterial action against Cutibacterium acnes and keratolytic effects 1, 2
- FDA labeling specifies use only for acne vulgaris with no mention of antiviral properties 3
- No mechanism of action against poxviruses
- No clinical trial evidence supporting efficacy in molluscum contagiosum
Tretinoin
- Designed to treat acne by normalizing follicular keratinization and reducing comedone formation 1, 2
- FDA labeling indicates use solely for acne vulgaris 4
- One case report actually documented treatment failure with topical tretinoin in an HIV patient with molluscum, requiring switch to glycolic acid 5
- A small study showed 10% benzoyl peroxide was more effective than 0.05% tretinoin for molluscum (30 participants), but this represents very low-quality evidence and benzoyl peroxide itself is not a recommended treatment 6
Evidence-Based Treatment Approaches for Molluscum
First-Line Options
Physical removal methods remain the standard of care 7, 8, 7:
- Incision and curettage (aggressive enough to cause bleeding)
- Simple excision
- Excision with cautery
- Cryotherapy
These physical methods directly remove viral lesions and allow host immune response to eliminate residual virus 7, 8, 7.
Alternative Topical Treatments (When Physical Methods Not Feasible)
Based on limited evidence, the following have shown some efficacy 9, 6:
Moderate evidence:
- 10% potassium hydroxide - appears more effective than saline, with similar efficacy to cryotherapy in children 9, 6
- Cantharidin - open-label studies show effectiveness, though one small RCT showed non-significant improvement over placebo 9, 6
Low-quality evidence:
- 10% Australian lemon myrtle oil
- 5% sodium nitrite co-applied with 5% salicylic acid
Important Caveat About Imiquimod
5% imiquimod showed NO benefit over placebo in high-quality evidence from multiple large trials 6:
- No difference in short-term cure (RR 1.33,95% CI 0.92-1.93)
- No difference in medium-term cure (RR 0.88,95% CI 0.67-1.14)
- No difference in long-term cure (RR 0.97,95% CI 0.79-1.17)
- Increased application site reactions (RR 1.41,95% CI 1.13-1.77)
Clinical Approach Algorithm
For symptomatic patients: Proceed with physical removal (curettage, cryotherapy, excision) 7, 8, 7
For patients refusing physical methods or with multiple lesions: Consider 10% potassium hydroxide or cantharidin 9, 6
For asymptomatic patients: Watchful waiting is reasonable as lesions spontaneously resolve in 6-12 months (up to 4 years) 9, 6
Special consideration: In adults with large/multiple lesions and minimal inflammation, evaluate for immunocompromised state 7, 8, 7
Key Pitfalls to Avoid
- Do not use acne medications (benzoyl peroxide, tretinoin) for viral infections - they lack antiviral mechanisms
- Do not rely on imiquimod - despite theoretical immune-modulating effects, high-quality RCTs show no benefit 6
- Identify nascent lesions when treating to reduce recurrence risk 7, 8, 7
- Expect delayed resolution of associated conjunctivitis (may take weeks after lesion removal) 7, 8, 7
The most evidence-based approach remains either watchful waiting for spontaneous resolution or physical removal methods, not topical acne medications.